Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

People born with heart defects and the clinicians who treat them can take heart in a U.S Food and Drug Administration panel's unanimous vote to recommend approval with conditions of a novel medical device that addresses the effects of a dysfunctional pulmonary valve without opening the chest for surgery. The pulmonary valve connects the heart to the lungs, where blood is enriched with oxygen before being pumped to the rest of the body.

Today in Drug/Product Approvals...keeping you current

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address